THEODORA KULESZA-GALVEZ
Allopathic & Osteopathic Physicians|Family Medicine SAN ANTONIO, TX NPI 1013323450
Browse related groups: Allopathic & Osteopathic Physicians|Family Medicine TX Amgen Inc. All categories
General Payments — all program years on this page
$984.05
- Category: General Payments
- Program years: PY2019–2024
- Record count: 61
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $137.93 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $137.93 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $54.47 | 3 |
| Novo Nordisk AS | $46.61 | 3 |
| ALK-Abello, Inc | $19.07 | 1 |
| Acerta Pharma LLC | $17.78 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1097336111 | Novo Nordisk Inc | $13.11 | 08/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097498604 | Novo Nordisk Inc | $15.01 | 05/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1097742642 | Novo Nordisk Inc | $18.49 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1099892327 | ALK-Abello, Inc | $19.07 | 11/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104542382 | AstraZeneca Pharmaceuticals LP | $17.78 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115835676 | Amgen Inc. | $20.74 | 02/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115835686 | Amgen Inc. | $13.98 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1115835694 | Amgen Inc. | $19.75 | 03/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.